Finastid en es it fr

Finastid Brand names, Finastid Analogs

Finastid Brand Names Mixture

  • No information avaliable

Finastid Chemical_Formula


Finastid RX_link

Finastid fda sheet

Finastid FDA

Finastid msds (material safety sheet)

Finastid Synthesis Reference

No information avaliable

Finastid Molecular Weight

372.544 g/mol

Finastid Melting Point

252-254 oC

Finastid H2O Solubility

11.7 mg/L

Finastid State


Finastid LogP


Finastid Dosage Forms


Finastid Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms, reduce the risk of acute urinary retention, reduce the risk of the need for surgery including transurethral resection of the prostat.

Finastid Pharmacology

Finasteride is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men only. Finasteride is a competitive and specific inhibitor of Type II 5a-reductase, an intracellular enzyme that converts the androgen testosterone into DHT. Two distinct isozymes are found in mice, rats, monkeys, and humans: Type I and II. Each of these isozymes is differentially expressed in tissues and developmental stages. In humans, Type I 5a-reductase is predominant in the sebaceous glands of most regions of skin, including scalp, and liver. Type I 5a-reductase is responsible for approximately one-third of circulating DHT. The Type II 5a-reductase isozyme is primarily found in prostate, seminal vesicles, epididymides, and hair follicles as well as liver, and is responsible for two-thirds of circulating DHT.

Finastid Absorption

No information avaliable

Finastid side effects and Toxicity

No information avaliable

Finastid Patient Information

No information avaliable

Finastid Organisms Affected

Humans and other mammals